» Articles » PMID: 2218974

Effects of Inflammation and Fibrosis on Pulmonary Function in Diffuse Lung Fibrosis

Overview
Journal Thorax
Date 1990 Sep 1
PMID 2218974
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the relation between lung function and inflammation and fibrosis in patients with diffuse lung fibrosis, a study was made of untreated patients without appreciable airway obstruction (14 patients with cryptogenic fibrosing alveolitis and seven with pneumoconiosis). Quantitative assessment of inflammatory infiltration and fibrosis was carried out on open lung biopsy specimens and compared with lung volumes, carbon monoxide transfer factor (TLCO), TLCO corrected for alveolar volume (TLCO/VA), and arterial blood gases at rest and during exercise. The degree of fibrosis and the degree of cellular infiltration were positively correlated. Lung volumes and TLCO were correlated with the grades of fibrosis and cellular infiltration of alveoli; arterial blood gases during exercise tended to correlate with both fibrosis and infiltration (p less than 0.06). In contrast, morphological data were not correlated with gas exchange at rest or with TLCO/VA. It is concluded that, in untreated patients with diffuse lung fibrosis, lung volumes, TLCO, and arterial blood gases during exercise reflect the lung lesions, and that the pulmonary function tests used cannot discriminate between fibrosis and infiltration of the lung by inflammatory cells.

Citing Articles

The correlation of symptoms, pulmonary function tests and exercise testing with high-resolution computed tomography in patients with idiopathic interstitial pneumonia in a tertiary care hospital in South India.

Isaac B, Thangakunam B, Cherian R, Christopher D Lung India. 2015; 32(6):584-8.

PMID: 26664164 PMC: 4663861. DOI: 10.4103/0970-2113.168131.


Pulmonary function testing in idiopathic interstitial pneumonias.

Martinez F, Flaherty K Proc Am Thorac Soc. 2006; 3(4):315-21.

PMID: 16738195 PMC: 2658684. DOI: 10.1513/pats.200602-022TK.


CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis.

Daniil Z, Kitsanta P, Kapotsis G, Mathioudaki M, Kollintza A, Karatza M Respir Res. 2005; 6:81.

PMID: 16042790 PMC: 1199622. DOI: 10.1186/1465-9921-6-81.


The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Thorax. 2000; 54 Suppl 1:S1-14.

PMID: 11006787 PMC: 1765921. DOI: 10.1136/thx.54.suppl_1.s1.


Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis.

Wells A Thorax. 1999; 53(12):1080-7.

PMID: 10195083 PMC: 1745154. DOI: 10.1136/thx.53.12.1080.


References
1.
GAENSLER E, CARRINGTON C . Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg. 1980; 30(5):411-26. DOI: 10.1016/s0003-4975(10)61291-x. View

2.
Haslam P, Turton C, HEARD B, Lukoszek A, Collins J, SALSBURY A . Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax. 1980; 35(1):9-18. PMC: 471213. DOI: 10.1136/thx.35.1.9. View

3.
Witschi H, Haschek W, Klein-Szanto A, Hakkinen P . Potentiation of diffuse lung damage by oxygen: determining variables. Am Rev Respir Dis. 1981; 123(1):98-103. DOI: 10.1164/arrd.1981.123.1.98. View

4.
Rudd R, Haslam P, TURNER-WARWICK M . Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis. 1981; 124(1):1-8. DOI: 10.1164/arrd.1981.124.1.1. View

5.
Crystal R, Bitterman P, Rennard S, HANCE A, Keogh B . Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med. 1984; 310(3):154-66. DOI: 10.1056/NEJM198401193100304. View